Board-certified psychiatrist Wayne Macfadden, MD provides psychiatric evaluation and treatment to Native American Indians as the psychiatrist at Spirit Lake Reservation in North Dakota. Specializing in the treatment of Substance Use Disorders, he provides medication assisted treatment (MAT) to eligible patients, which includes using naltrexone to treat alcohol use disorders and buprenorphine for opiate use disorders. Wayne Macfadden, MD is the reservation’s first full-time psychiatrist and spearheaded the formation of one of the few Suboxone treatment clinics on Indian reservations.
Contact Details
Tags
wayne macfaddenschizophreniamental healthwayne macfadden mdplacebo effectsubstance abusetreatmentsubstance useopioid disorderbipolar disorderclinical trialsdr. wayne macfaddenmedical possession ration (mpr)technological addictionstreatmentspsychiatristseligibilitymedication-assisted treatmentfrequently asked questionscholinesterase inhibitorsdementiapsychiatric associationpsychiatric medicationquestions to askmậtopiate use disorderaddiction issuespharmaceutical
Board-certified psychiatrist Wayne Macfadden, MD provides psychiatric evaluation and treatment to Native American Indians as the psychiatrist at Spirit Lake Reservation in North Dakota. Specializing in the treatment of Substance Use Disorders, he provides medication assisted treatment (MAT) to eligible patients, which includes using naltrexone to treat alcohol use disorders and buprenorphine for opiate use disorders. Wayne Macfadden, MD is the reservation’s first full-time psychiatrist and spearheaded the formation of one of the few Suboxone treatment clinics on Indian reservations.
Tags
wayne macfaddenschizophreniamental healthwayne macfadden mdplacebo effectsubstance abusetreatmentsubstance useopioid disorderbipolar disorderclinical trialsdr. wayne macfaddenmedical possession ration (mpr)technological addictionstreatmentspsychiatristseligibilitymedication-assisted treatmentfrequently asked questionscholinesterase inhibitorsdementiapsychiatric associationpsychiatric medicationquestions to askmậtopiate use disorderaddiction issuespharmaceutical
